rs13403592
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000599.4(IGFBP5):c.*2305G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0589 in 152,586 control chromosomes in the GnomAD database, including 380 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.059 ( 380 hom., cov: 32)
Exomes 𝑓: 0.042 ( 0 hom. )
Consequence
IGFBP5
NM_000599.4 3_prime_UTR
NM_000599.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.629
Publications
3 publications found
Genes affected
IGFBP5 (HGNC:5474): (insulin like growth factor binding protein 5) Enables insulin-like growth factor I binding activity. Involved in several processes, including cellular response to cAMP; regulation of smooth muscle cell migration; and regulation of smooth muscle cell proliferation. Part of insulin-like growth factor ternary complex. Biomarker of pulmonary fibrosis. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0587 AC: 8936AN: 152114Hom.: 370 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
8936
AN:
152114
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0424 AC: 15AN: 354Hom.: 0 Cov.: 0 AF XY: 0.0446 AC XY: 9AN XY: 202 show subpopulations
GnomAD4 exome
AF:
AC:
15
AN:
354
Hom.:
Cov.:
0
AF XY:
AC XY:
9
AN XY:
202
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
15
AN:
332
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
0
AN:
10
Other (OTH)
AF:
AC:
0
AN:
12
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0590 AC: 8978AN: 152232Hom.: 380 Cov.: 32 AF XY: 0.0585 AC XY: 4358AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
8978
AN:
152232
Hom.:
Cov.:
32
AF XY:
AC XY:
4358
AN XY:
74452
show subpopulations
African (AFR)
AF:
AC:
4436
AN:
41508
American (AMR)
AF:
AC:
764
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
58
AN:
3472
East Asian (EAS)
AF:
AC:
386
AN:
5178
South Asian (SAS)
AF:
AC:
495
AN:
4822
European-Finnish (FIN)
AF:
AC:
259
AN:
10614
Middle Eastern (MID)
AF:
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2372
AN:
68014
Other (OTH)
AF:
AC:
98
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
416
832
1247
1663
2079
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
287
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.